What the DEA’s Latest Telehealth Prescribing Extension Signals About the Future of Behavioral Health Care

On December 31, 2025, the Drug Enforcement Administration (DEA), in coordination with the Department of Health and Human Services, issued a fourth temporary extension of COVID-era telemedicine prescribing flexibilities. This extension allows DEA-registered clinicians to continue prescribing Schedule II–V controlled substances via telemedicine — without requiring an initial in-person visit — through December 31, 2026, provided all other federal […] The post What the DEA’s Latest Telehealth Prescribing Extension Signals About the Future of Behavioral Health Care appeared first on Iris Telehealth